These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 38540182)

  • 1. Nephrotic Syndrome: From Pathophysiology to Novel Therapeutic Approaches.
    Frățilă VG; Lupușoru G; Sorohan BM; Obrișcă B; Mocanu V; Lupușoru M; Ismail G
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diuretic Resistance.
    Hoorn EJ; Ellison DH
    Am J Kidney Dis; 2017 Jan; 69(1):136-142. PubMed ID: 27814935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasuria-The impact of active urinary proteases on sodium retention in nephrotic syndrome.
    Artunc F; Wörn M; Schork A; Bohnert BN
    Acta Physiol (Oxf); 2019 Apr; 225(4):e13249. PubMed ID: 30597733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology, Evaluation, and Management of Edema in Childhood Nephrotic Syndrome.
    Ellis D
    Front Pediatr; 2015; 3():111. PubMed ID: 26793696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aprotinin prevents proteolytic epithelial sodium channel (ENaC) activation and volume retention in nephrotic syndrome.
    Bohnert BN; Menacher M; Janessa A; Wörn M; Schork A; Daiminger S; Kalbacher H; Häring HU; Daniel C; Amann K; Sure F; Bertog M; Haerteis S; Korbmacher C; Artunc F
    Kidney Int; 2018 Jan; 93(1):159-172. PubMed ID: 29042083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over- or underfill: not all nephrotic states are created equal.
    Bockenhauer D
    Pediatr Nephrol; 2013 Aug; 28(8):1153-6. PubMed ID: 23529637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edematous disorders: pathophysiology of renal sodium and water retention and treatment with diuretics.
    Abraham WT; Schrier RW
    Curr Opin Nephrol Hypertens; 1993 Sep; 2(5):798-805. PubMed ID: 7922221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiloride resolves resistant edema and hypertension in a patient with nephrotic syndrome; a case report.
    Hinrichs GR; Mortensen LA; Jensen BL; Bistrup C
    Physiol Rep; 2018 Jun; 6(12):e13743. PubMed ID: 29939487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New insights into the pathophysiology of oedema in nephrotic syndrome].
    Rondon-Berrios H
    Nefrologia; 2011; 31(2):148-54. PubMed ID: 21461007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium retention in nephrotic syndrome is independent of the activation of the membrane-anchored serine protease prostasin (CAP1/PRSS8) and its enzymatic activity.
    Essigke D; Bohnert BN; Janessa A; Wörn M; Omage K; Kalbacher H; Birkenfeld AL; Bugge TH; Szabo R; Artunc F
    Pflugers Arch; 2022 Jun; 474(6):613-624. PubMed ID: 35312839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rodent models to study sodium retention in experimental nephrotic syndrome.
    Xiao M; Bohnert BN; Grahammer F; Artunc F
    Acta Physiol (Oxf); 2022 Jul; 235(3):e13844. PubMed ID: 35569011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Furosemide and albumin for the treatment of nephrotic edema: a systematic review.
    Hedin E; Bijelić V; Barrowman N; Geier P
    Pediatr Nephrol; 2022 Aug; 37(8):1747-1757. PubMed ID: 35239032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diuretic resistance: mechanisms and therapeutic possibilities].
    Imbs JL; Grima M; Stephan D
    Arch Mal Coeur Vaiss; 1998 Nov; 91(11):1383-8. PubMed ID: 9864608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretics in renal failure.
    Andreucci M; Russo D; Fuiano G; Minutolo R; Andreucci VE
    Miner Electrolyte Metab; 1999; 25(1-2):32-8. PubMed ID: 10207256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure].
    Christ M; Ludwig N; Maisch B
    Herz; 2002 Mar; 27(2):135-49. PubMed ID: 12025459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Draining the edema: a new role for aquaretics?
    Bockenhauer D
    Pediatr Nephrol; 2014 May; 29(5):767-9. PubMed ID: 24482024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental nephrotic syndrome leads to proteolytic activation of the epithelial Na
    Bohnert BN; Essigke D; Janessa A; Schneider JC; Wörn M; Kalo MZ; Xiao M; Kong L; Omage K; Hennenlotter J; Amend B; Birkenfeld AL; Artunc F
    Am J Physiol Renal Physiol; 2021 Oct; 321(4):F480-F493. PubMed ID: 34423678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Perspectives in Management of Edema in Nephrotic Syndrome.
    Meena J; Bagga A
    Indian J Pediatr; 2020 Aug; 87(8):633-640. PubMed ID: 32232733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into diuretic use in patients with chronic renal disease.
    Wilcox CS
    J Am Soc Nephrol; 2002 Mar; 13(3):798-805. PubMed ID: 11856788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.